Abstract
Patients with metastatic renal cell carcinoma (RCC) to the skeleton are evaluated by the orthopedic surgeon either directly because of unknown cause of skeletal pain or by referral from primary physicians, medical oncologists, or urologists after a lesion of bone is identified. Often a cancer diagnosis is well appreciated and the patient may have already had a nephrectomy and/or ongoing adjuvant therapy. Because of bone pain or a positive bone scan, the orthopedic surgeon is requested to evaluate and assess the structural integrity of long bones and the spine. In situations where a lytic lesion is visualized and the actual diagnosis is unknown, the surgeon embarks upon the differential diagnostic workup. Although all orthopedic surgeons are trained to diagnose and surgically manage metastatic disease, metastatic tumor cases can be just as challenging as primary sarcomas of bone and are often referred to orthopedic surgical oncologists, who are well versed in the complexity and management pitfalls of these lesions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Quinn JM, Matsumara W, Tarin D, et al. Cellular and hormonal mechanisms associated with malignant bone resorption, Lab. Investigat., 71 (1994) 465–471.
Teitelbaum SL and Ross FP. Mechanisms of tumor-induced osteolysis, Editorial, Lab. Investigat., 71 (1994) 453–455.
Kriteman L and Sanders WH. Normal alkaline phosphatase levels in patients with bone metastasis due to renal cell carcinoma, Urology, 51 (1998) 397–399.
Henriksson C, Haraldsson G, Aldenborg F, et al. Skeletal metastases in 102 patients evaluated before surgery for renal cell carcinoma, Scand. J. Urol. Nephrol., 26 (1992) 363–366.
Seaman E, Goluboff ET, Ross S, and Sawczuk IS. Association of Radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma, Urology, 48 (1996) 692–695.
Sandock DS, Sefter AD, and Resnick MI. A new protocol for follow up of renal cell carcinoma based on pathologic stage, J. Urol., 154 (1) (1995) 28–31.
Nemoto R, Nakamura I, Nishijima Y, et al. Serum pyridinoline cross-links as marker of tumor-bone resorption, Brit. J. Urol., 80 (1997) 274–280.
Shukla SK, Limouris GS, Cusumano R, et al. Renal cell carcinoma detection and systemic therapy with tumour-affinity gallium 67 and Yttrium- 90 citrate solutions, Anticancer Res., 17 (1997) 1713–1718.
Roscoe M, McBloom R, St. Louis E, et al. Preoperative embolization in treatment of osseous metastasis from renal cell carcinoma, Clin. Orth. Rel. Res., 238 (1989) 302–307.
Olerud C, Jonsson H, Lofberg A, et al. Embolization of spinal metastases reduces preoperative bone loss. 21 patients operated on for renal cell carcinoma, Acta Ortho. Scand., 64 (1993) 9–12.
Miller D, Haines G, Juliano P, and Ghoshs B. Preoperative embolization of osseous metastases from hypervascular cancers, J. Surg. Oncol., 60 (1995) 133, 134.
Skinner DG, Colvin RB, Vermillion CD, Pfister RC, and Leadbetter WF. Diagnosis and management of renal cell carcinoma: clinical and pathological study of 309 cases, Cancer, 28 (1971) 1165–1177.
Thompson IM, Shannon H, Ross J, and Montie J. An analysis of factors affecting survival of 150 patients with renal cell carcinoma, J. Urol., 114 (1975) 694–696.
Dekernion JB, Ramming KP, and Smith RB. The natural history of metastatic renal cell carcinoma: a computer analysis, J. Urol., 120 (1978) 148–152.
Maldazys JD and Dekernion JB. Prognostic factors in metastatic renal carcinoma, J. Urol., 136 (1986) 376–379.
Tobisu K, Kakizoe T, Takai K, and Tanaka Y. Prognosis in renal cell carcinoma: analysis of clinical course following nephrectomy, Japan J. Clin. Ocol., 19 (1989) 142–148.
Smith E, Kursh E, Makley J, and Resnick M. Treatment of osseous metastases secondary to renal cell carcinoma, J. Urol., 184 (1992) 784–787.
Althausen P, Althausen A, Jennings CL, and Mankin HJ. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma, Cancer, 80 (1997) 1103–1109.
Les KA, Nicholas RW, Simon MA, et al., Local progression and survival after operative resection of skeletal metastases from renal cell carcinoma, Abstract/Presentation Paper 184, Am. Acad. Orthopaed. Ann. Meet., February 1999.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Joyce, M.J. (2000). Management of Skeletal Metastases in Renal Cell Carcinoma Patients. In: Bukowski, R.M., Novick, A.C. (eds) Renal Cell Carcinoma. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-229-6_16
Download citation
DOI: https://doi.org/10.1007/978-1-59259-229-6_16
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-6401-7
Online ISBN: 978-1-59259-229-6
eBook Packages: Springer Book Archive